Quantitative Chemical Proteomics Reveals New Potential Drug Targets in Head and Neck Cancer
Open Access
- 1 December 2011
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 10 (12)
- https://doi.org/10.1074/mcp.m111.011635
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Deciphering Membrane-Associated Molecular Processes in Target Tissue of Autoimmune Uveitis by Label-Free Quantitative Mass SpectrometryMolecular & Cellular Proteomics, 2010
- Addressing Accuracy and Precision Issues in iTRAQ QuantitationMolecular & Cellular Proteomics, 2010
- Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neckHead & Neck, 2010
- The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell CarcinomaCancer Research, 2009
- Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinomaHead & Neck, 2008
- The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic TargetingMolecular Cancer Research, 2008
- Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsNature Biotechnology, 2007
- The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell linesOral Oncology, 2006
- RETRACTED ARTICLE: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinomaOncogene, 2004
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998